pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3675 |
Genomic Coordinates | chr1: 16858949 - 16859021 |
Description | Homo sapiens miR-3675 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3675-5p | |||||||||||||||||||||||||||||||||||||||||||||||||||
Sequence | 12| UAUGGGGCUUCUGUAGAGAUUUC |34 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | MORC2 | ||||||||||||||||||||
Synonyms | CMT2Z, ZCW3, ZCWCC1 | ||||||||||||||||||||
Description | MORC family CW-type zinc finger 2 | ||||||||||||||||||||
Transcript | NM_014941 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on MORC2 | |||||||||||||||||||||
3'UTR of MORC2 (miRNA target sites are highlighted) |
>MORC2|NM_014941|3'UTR 1 AGGCAGGAGAGAGAGCAGCTCCCCTGCCCACCTGCCCCTCAACCCTGTAGCTGCAGGGGGAGGGGACTTCATTCATGGGT 81 TGGTGGTCGCACCTTGGTTTGACTTACACGGGACATTTGTGTTTTTGGAGGAAAAGATACCCTGATTCTTTGAATCTTCC 161 TTAAGTTTATAAATATTTATTTTTTAAAAGAAGATGCTGTGCCTGTGAGACCATACTTTTTTTTTTTTTTTTTTTTTTTT 241 TTTTTTTTTTTTGGTGACTGCAAAGGACAGAGAACCTTTCCACTTTGGCCATACTGGGTTGCTAAGCCGGAGCCATTTCA 321 GCTCCTGGCTCCTCAAGATAACGGCGAGTCCAGTGCCATCTTGGAGAAGCTCCAGGGGCAGGGCTGACTTTTCTCCTACA 401 GGAGGAACAATGTGGGGATCTGAGGGATGGGAGGGAGACTTCCCCCTAGAGTGGTGGTCCTGCTGGGGGCTCATATCCAG 481 GGACCCAAAAGGGGGGCTGTGTAGGAGGTTCCACATTGGAGGGGCTCTCTCTCTCGCAGCTGTCAGAGTTGGTCCTGGCT 561 GTGGCGTCCAAACAGCTTGAGGGAAAAAGATCCTGTCTAACCACCTCATCTACTACTCAAGTTCTTTCTGAAGGAGGGAT 641 TTCTTCAGTTAACCATGGACAGTGAGGTTTCTCACCACAGTAACTTGAGTCCAGGTTGAGGGGGAGACAGATCTGTGGTA 721 AATCTCTGACTTGGGCAGCACACTGAGTGTGGAACCCCACAGGACTCCTTAGGGAAGGAGCTTGTGTGTGAAAGAACCCC 801 TGGGGCTGAGCTGGTGACCTCCATGTGTGGGTGCAGCAGGGCCTTGGATGGTGCCAATTGATCTGGACAGCCTGTTGATG 881 CTTTTCTACTTCCACCCTTCGGCCTGGCCCCACTGAGCCCCATCAAGGTGCCTGAAGAGGGGGCCAGTGAGATCCCGTGG 961 CCACAGGGACTCCAGAGGCATCTCTGCAGGAAGCACACCATGCCTTCCCTCCATGTTCCATCACGGCGCCACAATCTGTG 1041 TCCCTTAACTTCTCAGGGTCAAAGACAAAGGCAAGCGTTGCTGAATTTTCTCTTTAATGGCCATTGGAAGAGTCTGGTTC 1121 AGTTTTTCCCAACTCTCTTCCCACTCGTATTTGGGGCCTCTGGGTTTTCTGAAGGCACAAGGACTGTGACTTTGTACCAC 1201 TAACCTGTGGTTCAAACCTGGGTGTGTTTCTGGCATCTCCCTAACCCAGATCAGCAATGGCCACCCTGCTCCTCTGAGGT 1281 CAGCAGAAGACTGGGAAGCAGAGGTGAGGGATGCAGGCCACACTGGAATGGGAAGTCTTTTCCCCACTGGATGTGCCTGT 1361 CTGGTGGGTTTTGGACCTTCCCAGACTACATCTCTAGGAGAGGCCTGTTTGGAGTAGTACACTGAGAGACCCTGGCCTCT 1441 TCTGCTGGAAGACTGTCCAAGTCTTGGGGTTTCTTGAGCTGGTGATTCCTCTGCCATCCTGCTCTCTCTCTTCATCTCAG 1521 GCAGCATGGGGTCCACTTTTGTCCCCAAACCTAATGTTTTAATCCAAATGCAAATTGGTTCCACATTTTTACTGGAGGGT 1601 AATCAGTTTTTAAAATTCACACACATGTAATCGAAACGCAATACTATAAAGTTCTACTGGTGAGACTCCTGAAAAAAAAA 1681 AAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | LCL35 | ||||||
Disease | MIMAT0018098 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1020022. RNA binding protein: AGO2. Condition:EBV B95-8-infected
... - Skalsky RL; Corcoran DL; Gottwein E; Frank et al., 2012, PLoS pathogens. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Skalsky RL; Corcoran DL; Gottwein E; Frank et al. - PLoS pathogens, 2012
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus linked to a number of B cell cancers and lymphoproliferative disorders. During latent infection, EBV expresses 25 viral pre-microRNAs (miRNAs) and induces the expression of specific host miRNAs, such as miR-155 and miR-21, which potentially play a role in viral oncogenesis. To date, only a limited number of EBV miRNA targets have been identified; thus, the role of EBV miRNAs in viral pathogenesis and/or lymphomagenesis is not well defined. Here, we used photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) combined with deep sequencing and computational analysis to comprehensively examine the viral and cellular miRNA targetome in EBV strain B95-8-infected lymphoblastoid cell lines (LCLs). We identified 7,827 miRNA-interaction sites in 3,492 cellular 3'UTRs. 531 of these sites contained seed matches to viral miRNAs. 24 PAR-CLIP-identified miRNA:3'UTR interactions were confirmed by reporter assays. Our results reveal that EBV miRNAs predominantly target cellular transcripts during latent infection, thereby manipulating the host environment. Furthermore, targets of EBV miRNAs are involved in multiple cellular processes that are directly relevant to viral infection, including innate immunity, cell survival, and cell proliferation. Finally, we present evidence that myc-regulated host miRNAs from the miR-17/92 cluster can regulate latent viral gene expression. This comprehensive survey of the miRNA targetome in EBV-infected B cells represents a key step towards defining the functions of EBV-encoded miRNAs, and potentially, identifying novel therapeutic targets for EBV-associated malignancies.
LinkOut: [PMID: 22291592]
|
CLIP-seq Support 1 for dataset GSM1020022 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | LCL35 / EBV B95-8-infected, 4-thiouridine, RNase T1 |
Location of target site | ENST00000397641.3 | 3UTR | UCAAGGUGCCUGAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22291592 / GSE41437 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
32 hsa-miR-3675-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT366903 | NONO | non-POU domain containing octamer binding | 2 | 2 | ||||||||
MIRT453894 | DUSP18 | dual specificity phosphatase 18 | 2 | 2 | ||||||||
MIRT461725 | ZNF426 | zinc finger protein 426 | 2 | 2 | ||||||||
MIRT464694 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | 2 | 2 | ||||||||
MIRT465957 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | 2 | 2 | ||||||||
MIRT466038 | TMEM189 | transmembrane protein 189 | 2 | 2 | ||||||||
MIRT471546 | PAX5 | paired box 5 | 2 | 2 | ||||||||
MIRT472813 | MTMR12 | myotubularin related protein 12 | 2 | 2 | ||||||||
MIRT474099 | LMBR1L | limb development membrane protein 1 like | 2 | 2 | ||||||||
MIRT480205 | CAD | carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 2 | 2 | ||||||||
MIRT488268 | HSP90AB1 | heat shock protein 90 alpha family class B member 1 | 2 | 8 | ||||||||
MIRT491222 | MRPL34 | mitochondrial ribosomal protein L34 | 2 | 2 | ||||||||
MIRT494768 | AP1G1 | adaptor related protein complex 1 gamma 1 subunit | 2 | 2 | ||||||||
MIRT497228 | MORC2 | MORC family CW-type zinc finger 2 | 2 | 2 | ||||||||
MIRT501676 | PFN1 | profilin 1 | 2 | 6 | ||||||||
MIRT511831 | H2AFX | H2A histone family member X | 2 | 4 | ||||||||
MIRT513880 | HNRNPUL1 | heterogeneous nuclear ribonucleoprotein U like 1 | 2 | 4 | ||||||||
MIRT519402 | DNASE2 | deoxyribonuclease 2, lysosomal | 2 | 4 | ||||||||
MIRT522627 | MAP7D1 | MAP7 domain containing 1 | 2 | 4 | ||||||||
MIRT546998 | PPP2CA | protein phosphatase 2 catalytic subunit alpha | 2 | 2 | ||||||||
MIRT555119 | PUM2 | pumilio RNA binding family member 2 | 2 | 2 | ||||||||
MIRT560380 | TIMM8A | translocase of inner mitochondrial membrane 8A | 2 | 2 | ||||||||
MIRT572188 | CDADC1 | cytidine and dCMP deaminase domain containing 1 | 2 | 2 | ||||||||
MIRT634822 | ASB6 | ankyrin repeat and SOCS box containing 6 | 2 | 2 | ||||||||
MIRT641149 | DNMBP | dynamin binding protein | 2 | 2 | ||||||||
MIRT647389 | ZNF616 | zinc finger protein 616 | 2 | 2 | ||||||||
MIRT670851 | SFT2D2 | SFT2 domain containing 2 | 2 | 2 | ||||||||
MIRT698600 | TEX261 | testis expressed 261 | 2 | 2 | ||||||||
MIRT698691 | TBPL1 | TATA-box binding protein like 1 | 2 | 2 | ||||||||
MIRT708725 | PTPLAD2 | 3-hydroxyacyl-CoA dehydratase 4 | 1 | 1 | ||||||||
MIRT718340 | SYNDIG1L | synapse differentiation inducing 1 like | 2 | 2 | ||||||||
MIRT725514 | FBXO46 | F-box protein 46 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|